“I’m far from trying to predict what’s going to happen,” UBS chief Sergio P. Ermotti told Semafor’s Liz Hoffman, at the World ...

(Reuters) - The incipient migration of clients from Credit Suisse to UBS should take about another 18 months, UBS CEO Sergio ...

With a focus on cancer and autoimmune conditions, UBS has launched its coverage of 13 small and mid-cap biotechs, noting that ...

UBS lowered the firm’s price target on Moderna (MRNA) to $108 from $140 and keeps a Buy rating on the shares following a model review.

UBS analyst Justin Forsythe maintained a Sell rating on Worldline (0QVI – Research Report) today and set a price target of €5.25. The ...

Donald Trump’s plan to slap steep tariffs on all imports if he is elected risks provoking trade wars that would hurt global ...

Inflation, high interest rates and political instability made the wealthiest clients become more cautious with art purchases ...

The Liberal-National opposition has unveiled a smaller headline election costings total, but the change to forecast debt is ...

SBI Life reported a 39% YoY growth in consolidated net profit, reaching Rs 529 crore in Q2 FY25. Net premium income rose 1% ...